Cysteamine as a topical management option for melasma

Clin Exp Dermatol. 2022 Mar;47(3):646-647. doi: 10.1111/ced.14958. Epub 2021 Nov 23.

Authors

S K Hira¹, R Nalluri²

Affiliations

¹ Department of Medicine, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
² Department of Dermatology, Manchester University NHS Foundation Trust Varna pigmentation, Manchester, UK.

PMID: 34816461
DOI: 10.1111/ced.14958

No abstract available

MeSH terms

Administration, Topical
Cysteamine / administration & dosage*
Dermatologic Agents / administration & dosage*
Humans
Intention to Treat Analysis
Melanosis / drug therapy*
Skin Cream
Treatment Outcome

Substances

Dermatologic Agents
Cysteamine